Table 1.
Variable demographics | Total patients (N = 492)a |
---|---|
Reason for testing | Number |
Injection drug user | 274 |
Recent exposure | 153 |
Past exposure | 7 |
Correctional screening | 23 |
Routine screening | 8 |
Confirmatory | 3 |
Not available/unknown | 24 |
Race | |
White | 474 |
Other or missing data | 18 |
Sex | |
Male | 313 |
Female | 179 |
County | |
Scott | 295 |
Clark | 64 |
Jackson | 65 |
Other | 68 |
Age (years) | |
<25 | 92 |
25–34 | 212 |
35–44 | 113 |
≥45 | 75 |
HCV molecular data | |
HCV RNA positive | 359 |
HIV Co-infected HCV RNA positive | 91 |
NS5B sanger sequencing | 299 |
HVR1 NG sequencing | 281 |
Sanger and/or NG sequencing | 329 |
HCV RNA positive, no sequencing results | 20 |
HCV Ab positive, PCR negative | 38 |
Acute HCV cases | 12 |
Reference HCV cases from 2010 | 10 |
Samples include anti-HCV and/or anti-HIV, anti-HCV and/or HCV RNA positive.